172 related articles for article (PubMed ID: 37927399)
1. METTL16 Inhibits the Malignant Progression of Epithelial Ovarian Cancer through the lncRNA MALAT1/
Li C; Liu J; Lyu Y; Ling S; Luo Y
Anal Cell Pathol (Amst); 2023; 2023():9952234. PubMed ID: 37927399
[TBL] [Abstract][Full Text] [Related]
2. LncRNA MALAT1 Facilitates Ovarian Cancer Progression through Promoting Chemoresistance and Invasiveness in the Tumor Microenvironment.
Mao TL; Fan MH; Dlamini N; Liu CL
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638541
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway.
Zhuang XH; Liu Y; Li JL
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31337688
[TBL] [Abstract][Full Text] [Related]
4. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
Zhang Y; Dun Y; Zhou S; Huang XH
Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
[TBL] [Abstract][Full Text] [Related]
5. MALAT1 affects ovarian cancer cell behavior and patient survival.
Lin Q; Guan W; Ren W; Zhang L; Zhang J; Xu G
Oncol Rep; 2018 Jun; 39(6):2644-2652. PubMed ID: 29693187
[TBL] [Abstract][Full Text] [Related]
6. STAT1-Induced Upregulation lncRNA LINC00958 Accelerates the Epithelial Ovarian Cancer Tumorigenesis by Regulating Wnt/
Xie M; Fu Q; Wang PP; Cui YL
Dis Markers; 2021; 2021():1405045. PubMed ID: 34790276
[TBL] [Abstract][Full Text] [Related]
7. LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K-AKT pathway.
Jin Y; Feng SJ; Qiu S; Shao N; Zheng JH
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3176-3184. PubMed ID: 28770968
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis.
Long X; Song K; Hu H; Tian Q; Wang W; Dong Q; Yin X; Di W
J Exp Clin Cancer Res; 2019 Aug; 38(1):345. PubMed ID: 31391118
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA MALAT1 regulates ovarian cancer cell proliferation, migration and apoptosis through Wnt/β-catenin signaling pathway.
Guo C; Wang X; Chen LP; Li M; Li M; Hu YH; Ding WH; Wang X
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3703-3712. PubMed ID: 29949143
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
Zeng S; Liu S; Feng J; Gao J; Xue F
Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA RHPN1-AS1 promotes tumorigenesis and metastasis of ovarian cancer by acting as a ceRNA against miR-596 and upregulating LETM1.
Wang J; Ding W; Xu Y; Tao E; Mo M; Xu W; Cai X; Chen X; Yuan J; Wu X
Aging (Albany NY); 2020 Mar; 12(5):4558-4572. PubMed ID: 32163372
[TBL] [Abstract][Full Text] [Related]
12. lncRNA CDKN2A-AS1 facilitates tumorigenesis and progression of epithelial ovarian cancer via modulating the SOSTDC1-mediated BMP-SMAD signaling pathway.
Zhao Q; Dong D; Chu H; Man L; Huang X; Yin L; Zhao D; Mu L; Gao C; Che J; Liu Q
Cell Cycle; 2021 Jun; 20(12):1147-1162. PubMed ID: 34110955
[TBL] [Abstract][Full Text] [Related]
13. CCT2 prevented β-catenin proteasomal degradation to sustain cancer stem cell traits and promote tumor progression in epithelial ovarian cancer.
Chen J; Hu Q; Zhou C; Jin D
Mol Biol Rep; 2024 Jan; 51(1):54. PubMed ID: 38165547
[TBL] [Abstract][Full Text] [Related]
14. Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis.
Yang X; Sun J; Xia D; Can X; Liu L; Zhang J; Xu H; Du N; Liu W; Shen F; Zhang Z; Sun Y; Xi X
Cell Physiol Biochem; 2017; 42(1):185-197. PubMed ID: 28535511
[TBL] [Abstract][Full Text] [Related]
15. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
Zhang C; Li Y; Zhao W; Liu G; Yang Q
Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655
[TBL] [Abstract][Full Text] [Related]
16. Exosomal Metastasis‑Associated Lung Adenocarcinoma Transcript 1 Promotes Angiogenesis and Predicts Poor Prognosis in Epithelial Ovarian Cancer.
Qiu JJ; Lin XJ; Tang XY; Zheng TT; Lin YY; Hua KQ
Int J Biol Sci; 2018; 14(14):1960-1973. PubMed ID: 30585260
[TBL] [Abstract][Full Text] [Related]
17. METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m
Dai YZ; Liu YD; Li J; Chen MT; Huang M; Wang F; Yang QS; Yuan JH; Sun SH
Cell Mol Biol Lett; 2022 May; 27(1):41. PubMed ID: 35596159
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of lncRNA ASMTL-AS1 in Epithelial Ovarian Cancer Correlates with Worse Prognosis and Cancer Progression.
Xu H; Tang Y; Liu L; Yan J; Qin L
Horm Metab Res; 2022 Jul; 54(7):481-488. PubMed ID: 35835145
[TBL] [Abstract][Full Text] [Related]
19. BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway.
Cao P; Zhao S; Sun Z; Jiang N; Shang Y; Wang Y; Gu J; Li S
Exp Cell Res; 2018 Oct; 371(1):214-221. PubMed ID: 30118697
[TBL] [Abstract][Full Text] [Related]
20. METTL16 promotes cell proliferation by up-regulating cyclin D1 expression in gastric cancer.
Wang XK; Zhang YW; Wang CM; Li B; Zhang TZ; Zhou WJ; Cheng LJ; Huo MY; Zhang CH; He YL
J Cell Mol Med; 2021 Jul; 25(14):6602-6617. PubMed ID: 34075693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
